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Abstract
Background: Platelet-rich plasma (PRP) contains numerous growth factors to promote wound healing and
angiogenesis. The aim of this study was to gain further information about the benefits of platelet-rich-plasma for
healing cutaneous acute to chronic wounds.
Methods: A total of 30 New Zealand albino rabbits (n = 15/group) were randomly assigned to two experimental
groups: control group, and PRP group. Bilateral resection defects measuring 3 cm were surgically created on the
dorsolateral of the cutaneous in animals and the defects were randomly divided into two mentioned groups.
Wound area, neovascularization, size and epithelialization were compared on days 7, 14 and 21 post-wounding.
Histopathological analyses were conducted on 15 specimens from each group after sacrifice by the cellular aspects
of the regeneration of the tissue.
Results: Our results were indicated that the wound area of PRP was smaller than that in the non-treated group
on days 7, 14 and 21. Furthermore, a significant decrease of the wound size was observed in PRP groups that
were significantly greater than that in the control group. A significant increase of the mean vascular density was
noted in the PRP treated groups compared to the control groups at day 14 and especially day 21. This results
indicated that PRP treated group’ enhanced angiogenesis at the wound beds as compared to no treatment
group.
Conclusion: These results could be useful for researchers in the growing fields of tissue repair and
experimental wound healing. Further studies will be essential to determine the role of PRP in clinical
practice.
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Background
Platelets play a central role in hemostasis and wound
healing. The latter is mediated by release of secretory
proteins on platelet activation, which directly or indir-
ectly influences virtually all aspects of the wound healing
cascade. A recent strategy to promote the wound-repair
cascade is to prepare an autologous platelet concentrate
suspended in plasma, also known as platelet-rich plasma
(PRP), that contains growth factors and administer it to
wound sites [1, 2].
Wound regeneration commonly begins with clot forma-
tion and platelet degranulation, leading to the release of
multifarious cytokines and coagulation factors, which
modulate inflammatory response. To date, more than 30
various cytokines have been detected in platelets. Among
those, platelet derived growth factors (PDGFs), transform-
ing growth factors (TGFs), vascular endothelial growth
factor (VEGF),epidermal growth factor (EGF), and Insulin-
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like growth factor (IGF) has been described that stimulate
cellular migration, proliferation and angiogenesis for suc-
cessful wound healing [3]. Platelet gel is produced by mix-
ing two solutions: PRP and calcified thrombin solution.
The PRP can be prepared by aphaeresis or can be separated
from fresh anti-coagulated blood by simple centrifugation,
which concentrates platelets up to six times the baseline
count in whole blood [4]. Animal studies and human trials
revealed successful results in regenerative potential of PRP,
suggesting that the administration of growth factors may
be combined with tissue regeneration techniques in the
repair of intra-bony defects, furcation’s, and cyst cavities to
improve the outcome of these treatments [5–9].
Furthermore, PRP was used in the treatment of chronic
cutaneous and soft tissue ulcerations [10–12]. There have
been numerous publications on the use of PRP for clinical
applications in periodontal and oral surgery [8, 11–14],
maxillofacial surgery [10–13], orthopedic and trauma sur-
gery [14–18], cosmetic and plastic surgery [19, 20], spinal
surgery [10, 11], heart bypass surgery [10], and burns [21].
Platelets in PRP also play a role in host defense mechan-
ism at the wound site by producing signaling proteins that
attract macrophages [13]; PRP also may contain a small
number of leukocytes [17, 20] that synthesize interleukins
as part of a non-specific immune response.
Methods
Ethics statement and animals
All experimental protocols were approved by the local ani-
mal care committee in accordance with Faculty of Shiraz
Veterinary Medicine office regulations. In current study,
30 New Zealand albino rabbits of both sexes, weighing
2400–4700 g, with averagely 3 weeks old were selected.
The animals were kept two by two in individual propylene
cages under standard laboratory conditions by the dimen-
sions of 45 × 60 × 90 cm3. Rabbits were maintained on a
12 h light/dark cycle at 22 ± 1 °C and 50 ± 10 % humidity,
and fed with standard rat diet and water ad libitum.
PRP preparation
Rabbit blood was collected from healthy animals in an
EDTA-coated container (BD Vacutainer®, Franklin Lakes,
NJ). PRP was isolated as previously described [21]. The
blood was centrifuged at 2,400 rpm for 10 min at room
temperature. After discarding the upper platelet-poor
plasma, the sample was further centrifuged at 3,500 rpm
for an additional 15 min, thereby separating the upper
PRP layer and the lower red blood cells- and white blood
cells-rich layer. The upper layer was collected carefully
using an auto-pipette.
Wound treatment
A rabbit model of hemorrhagic shock was established as
described previously. Briefly, New Zealand albino rabbits
were anesthetized via intramuscular injection of ketamine
(21 mg/kg body weight) and xylazine (2.2 mg/kg body
weight). A 3 cm sized skin defect was created on the back
of each rabbit with surgical scissors. Epidermis, dermis,
and SC were removed, and the muscle fascia was exposed.
In order to prevent the wound by contracture, 4 sutures
were placed at the border of the wound with 6–0 sutures
(Ethicon, Somerville, NJ) and the wound margins were an-
chored to the underlying muscle fascia. The wounds were
treated once with a total 200 μl of PRP (n = 7). PRP was
formed on the wounds by directly applying 100 μl of PRP
on each of the wounds and the wounds were covered with
polyurethane film. The films covering the wounds were
changed every 7 days to take macroscopic pictures of the
wounds. Platelet-rich plasma (PRP) was separated by cen-
trifugation for 15 min at 300 xg, and the plasma proteins
were concentrated together with the platelets using the
cold ethanol precipitation method. The animals were indi-
vidually housed after surgery. The animal study proce-
dures were approved by the Institutional Animal Care and
Use Committee at Shiraz University.
Experimental protocol and evaluation of wound healing
The rabbits were randomly allocated into two groups,
each group containing fifteen submitted animals. Two
symmetrical wounds were created on either side of the
back of each rabbit that were made in the laterodorsal
cutaneous. It is worth noting that one wound was as con-
trol group and PRP was applied on wound in PRP group
(Fig. 1). Both wounds were then covered with a polyureth-
ane film, and evaluated macroscopically and histologically
on days 7, 14 and 21 after the operation.
Fig 1 Cutaneous lesions of PRP rabbit after 1 week: the lesion is
humid and non to mild -exudative, with marginal epithelization
starting from the lesion edges, the wound is <100 % epithelialized,
with marked fibrin deposition. There is moderate erythema of the
peri and intra-wound area and firm









The wounds were evaluated macroscopically and histo-
logically. For macroscopic evaluation of wound healing,
each wound edge was traced and all rabbits were eutha-
nized of the surgical procedure by carbon dioxide inhal-
ation at days 7, 14 and 21. The wounds were sampled in
full-thickness, including the underlying muscle. For the
biopsy, we used an 8-mm diameter dermal biopsy punch
(Stiefel Laboratories®). All specimens were used for histo-
logical analysis. The histological specimens were fixed in
formalin, embedded in paraffin, sectioned transversely
(4 μm tick). Then, transverse sections were stained with
hematoxylin and eosin (H&E) for histological examination.
Results
Observation and closure of macroscopic wounds
The wounds were evaluated macroscopically and histo-
logically on the 7th, 14th and 21st after the wound
creation. Totally, the macroscopic findings in the PRP-
treated groups were improved and organized than the
control groups (Figs. 1, 2 and 3). On the other hand, the
percentage decrease of the wound size in PRP groups
was significantly greater than that in the control group,
which these findings showed a significant difference in the
percentage decrease of the wound area between the PRP
and control groups (Figs. 1, 2 and 3). The PRP group was
demonstrated significantly smaller wound size compared
to the non-treated groups at days 14 and 21. The wound
sizes of control groups were not significantly different
from those of no treatment group at day 14 and day 21.
Histological observation
The histopathological examination indicated that there
were significant differences in the pattern of wound heal-
ing among the two groups. There were significant differ-
ences between the treated groups with PRP and control
group in the mean percentage of collagen fibres at days
14 and 21. Furthermore, by day 7, there were increased
newly organized collagen bundles and relatively ad-
vanced epithelium at the wound junction of PRP-treated
wounds revealed as compared to non-treated wounds
(Fig. 4). In parallel, on day 7, several small vessels
(angiogenesis) were also apparent in the PRP treated tis-
sues, whereas only a few vessels were present in control
tissues. Because organized collagen fibers give tensile
strength to the tissue, the arrangement of collagen ob-
served in the experimental group is consistent with tis-
sues that possess good tensile strength and improved
wound healing. A significant increase of the mean vascu-
lar density was noticeable in the PRP treated groups
compared to control groups at day 14 and especially day
21. Therefore, it can be concluded that PRP treated
group’ enhanced angiogenesis at the wound beds in
comparison with no treatment groups (Figs. 5 and 6).
Moreover, by days 14 and 21, all wounds contained
abundant fibroblasts and collagen bundles, through rich
neovascularization were detected only in the PRP-
treated wounds (Figs. 5 and 6). Furthermore, in PRP
Fig 2 Wound area on day 14. Percentage decrease in the wound
size. The generation of granulation tissue and the re-epithelialisation
observed in the wounds covered with PRP are clearly superior to
that in the control wound, which shows few signs of healing; there
is mild erythema of the peri-wound area and firm, black granulation
tissue in the wound bed
Fig 3 Day 21 of cutaneous wound healing with PRP in the treatment
group: The wound has healed after tree applications of PRP; the
wound is clearly contracted in all dimensions. The margins are intact,
and there is noticeably less bleeding with debridement. And also, the
percentage decrease in the wound size was significantly greater in the
week 3 as compared with 14 days expressed









group, inflammatory responses were observed at lower
frequency range than the control groups at 14 and
21 days. It is worth noting that the results were better in
study group than in the control group.
Discussion
Emerging new therapies such as PRP can have an ad-
junctive role in a standardized, quality treatment plan.
The application of autologous PRP to soft tissue healing
has been a subject of great interest for much of the past
two decades. Multiple growth factors are present in high
concentrations within PRP. Some of the most important
of these include PDGF, TGF-β, VEGF, EGF, and IGF.
PDGF, TGF-β, VEGF, and EGF have been shown to be
increased 3 to 7 times in autologous PRP [22, 23]. More-
over, platelet concentrates contain many powerful mito-
genic and chemotactic growth factors, which regulate
key processes involved in tissue repair, including cell
proliferation, chemotaxis, migration, cellular differenti-
ation, and extracellular matrix synthesis [24, 25].
The results of this study appear to confirm observa-
tions from the basic science of wound repair; in the large
number of wounds, a positive change in wound variables
was seen following application of physiologically relevant
concentration of platelets. These findings are important
because, while the PRP injection remain the gold stand-
ard for determining treatment efficacy [26]. Further-
more, we have revealed the benefits of topical platelet-
rich plasma gel for the treatment of the laterodorsal cu-
taneous wounds. Our study have shown that wounds
treated with PRP exhibited faster healing rates and ad-
equate granulation tissue formation when compared to
wounds treated with non-treated group. In addition, top-
ical use of PRP has been shown to enhance angiogenesis
in the early stage of the repair process after open skin
and subsequently to promote wound healing.
Fig 4 Post-wound tissue stained with hematoxylin and eosin.
Representative skin from a PRP wound 7 days after wounding with
increased inflammatory cells and new collagen fiber bundles are
sparse, which these fibers do not fill in between the intact collagen
bundles (200Ҳ, B = 10 μm)
Fig 5 Histopathologic section of wound related to treatment group,
14 day post-wounding, indicates vascular density on day14. Tissue
from the PRP-treated wound at day 14. New collagen bundles filled
densely, new blood vessels are found in the deep dermal layer only
in the PRP-treated wounds (H&E,200 Ҳ B = 10 μm)
Fig 6 Photomicrograph in experimental all groups in cutanenous
wound at 21th day. Mature epithelial cells are obvious in PRP
treated wounds obtained 21 days after wounding. Proliferative
activity in the epidermis is higher in this tissue, Note complete
wound healing. The presence of epidermis layer cover the mature
granulation tissue (H&E,400 Ҳ B = 20 μm)









According to the scope of the present study the effect
of PRP in wound healing indicated similar positive result
of PRP in acceleration of epithelial migration, the angio-
genic response and tissue fill. In parallel, several clinical
studies, in both human and veterinary medicine, on the
restoration of tissue integrity have shown the positive
role of platelets in natural wound healing [27–29]. When
locally applied, platelets accelerate healing of normal
tissue and promote healing of impaired wounds [30, 31].
Furthermore, Sharma and Maffulli have been reported
that collagen is produced by epitenon cells at the initial
stage of the healing process, whereas endotenon cells
synthesized collagen later [32]. However, these results is in
agreement with those studies induced by Lee et al., that
have noted acceleration of epithelialization in treatment of
lower equine wound with PRP [33] and faster resolution
in inflammatory response. Moreover, Vaterio et al., have
been shown acceleration in skin reepithelialization by
using PRP during fat grafting in patient who underwent
plastic surgery [34]. In previous study, Alsabaawe, Hom
et al., have been suggested an increased of epithelializa-
tion rate and regression of acute inflammatory process
in PRP treated skin wounds in rabbits during week 1
postoperative period compared to week 2 where there
was no statistical differences found in epithelial thickness
and inflammation stage between PRP treated wound and
control. Also, they indicated that the epithelialization
returned to normal texture and improvement of wound
healing in term of reducing the inflammatory process
[35, 36]. On the other hand, Ahmad et al., (2012) suggested
that the PRP has the potential to enhance the healing of
tissue at the cellular level via the recruitment proliferation,
and differentiation of cells involved in tissue regeneration
[37] Moreover, Gotterbarm et al., (2006) have been re-
ported the PRP acts as a rich source of autologous growth
factors [38]. Sun et al., (2010) have been mentioned that,
PRP is a very good clinical source for osteochondral regen-
eration [39]. On the other hand, Shin et al., (2012) proved
that PRP was effective in normal tissue regeneration [40].
These researches are in agreement with our study. More-
over, recent studies demonstrated that histopathological
examinations are gold standards as diagnostic criteria in
the experimental animals on the different fields [41–45].
Conclusions
The results of systematic review and hisological analysis
revealed that wound healing time of PRP treatment
group was shorter than that of control group. These re-
sults could be useful for researchers in the growing fields
of tissue repair and experimental wound healing. Further
studies will be essential to determine the role of PRP in
clinical practice. Controlled studies with sufficient sam-
ple sizes are needed to prove the efficacy of platelet-rich
plasma to treat wounds.
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